"ICON Public Limited Company (NASDAQ:ICLR): The stock pulled back on news that biotechnology funding has dropped, albeit from ...

Leading Value Strategy Consultancy Deepens ICON's Pricing and Market Access Capabilities DUBLIN, Feb 28, 2012 (BUSINESS WIRE) -- ICON plc, ICLR -0.09% (isin:IE0005711209), a global provider of ...

DUBLIN, Nov. 5, 2015 /PRNewswire/ -- ICON plc, () a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced ...

Clinical research organisation (CRO) Icon has begun the integration of Medidata Clinical Data Studio into its clinical studies. This development makes Icon the first CRO to completely integrate ...